NEW YORK (AP) — U.S. health officials on Wednesday recommended that people 50 and older get a shot against bacteria that can ...

In a 15-0 vote, ACIP recommended that MenB-4C be administered as a two-dose series at 0 and 6 months when given to healthy ...

Southwest District Health will no longer offer the COVID-19 vaccine to residents who want to pay for it. The health ...

The CDC now says everyone 50 to 64 years old should get a pneumococcal vaccine to help protect against serious illnesses like pneumonia, meningitis, and bloodstream infections.

U.S. health officials are recommending that people 50 and older get a shot against bacteria that can cause pneumonia and ...

The committee voted to lower the recommended age for MSD’s Capvaxive and Pfizer’s Prevnar 20 to 50 years down from 65.

All adults aged 50 and older should receive a vaccine against bacteria that can cause pneumonia and meningitis, federal ...

An agency panel recommended lowering the age for routine vaccination from 65 to 50, boosting the revenue outlook for multiple ...

“Pfizer is at the forefront of vaccine and therapeutic development in respiratory and infectious diseases,” said Annaliesa Anderson, Ph.D., Senior Vice President and Head, Vaccine Research and ...

The two companies brought legal action over a repeated sequence in the messenger RNA (mRNA) used in CureVac's patents in life-saving coronavirus jabs. Lawyers for Pfizer and BioNTech claimed that ...

which underpins Pfizer and BioNTech's COVID-19 vaccine. Tuesday's ruling relates to the London leg of Pfizer, BioNTech and CureVac's global legal battle, which also involves litigation in the ...